{ "run": { "id": "cmnr145r704a5p658lfti2uwk", "region": "US", "assetId": "cmnr145q7049yp658u9u079ig", "ticker": "HSIC", "snapshotId": "cmnr145qm04a2p658511gj2fu", "promptTemplateId": "cmnqt07si0005lm3jzpxuu1ux", "createdAt": "2026-04-09T05:21:04.289Z", "promptTemplate": { "id": "cmnqt07si0005lm3jzpxuu1ux", "name": "Oficial 08.apr.2026", "version": 1 }, "snapshot": { "id": "cmnr145qm04a2p658511gj2fu", "assetId": "cmnr145q7049yp658u9u079ig", "asOf": "2026-04-08T20:00:02.000Z", "snapshot": { "asOf": "2026-04-08T20:00:02.000Z", "quote": { "asOf": "2026-04-08T20:00:02.000Z", "open": null, "price": 75.53, "dayLow": 73.91, "volume": 1483422, "dayHigh": 76.65, "currency": "USD", "prevClose": 73.85, "week52Low": 60.56, "week52High": 89.29 }, "fundamentals": { "pe": 23.2614840989399, "beta": 0.857126780984949, "epsTTM": 2.83, "fcfTTM": 401013000, "growth": { "epsYoy": 0.07166123778501636, "revenueYoy": 0.04032194429101239 }, "sector": "Wholesale-Medical, Dental & Hospital Equipment & Supplies", "margins": { "net": 0.03018810679611651, "gross": 0.3113622572815534, "operating": 0.04952973300970874 }, "website": "http://henryschein.com", "industry": null, "pegRatio": -0.584646926550897, "ebitdaTTM": 837505000, "forwardPe": 18.1850828729282, "marketCap": 8885457000, "totalCash": 156000000, "totalDebt": 3074000000, "debtEquity": 0.175958403570665, "quickRatio": 0.5597893432465924, "revenueTTM": 13184000000, "companyName": "HENRY SCHEIN INC", "priceToBook": 2.17552309277834, "currentRatio": 1.382899628252788, "dividendYield": null, "returnOnAssets": 0.03548818546589389, "returnOnEquity": 0.120601331114411, "analystOpinions": null, "businessSummary": "Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners.", "enterpriseValue": 9548992320, "analystTargetLow": null, "analystTargetHigh": null, "analystTargetMean": null, "fullTimeEmployees": 25000, "sharesOutstanding": 114704121, "enterpriseToEbitda": 11.4017138046937, "analystTargetMedian": null, "enterpriseToRevenue": 0.7242864320388349, "operatingCashflowTTM": 712000000, "analystRecommendationKey": null } }, "createdAt": "2026-04-09T05:21:04.270Z" }, "results": [ { "id": "cmnr145ra04a7p658425ao8dd", "runId": "cmnr145r704a5p658lfti2uwk", "modelId": "anthropic", "status": "SUCCESS", "rawOutput": "{\"model\":\"claude-3.5-ai-equity-research\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"HSIC\",\"currency\":\"USD\",\"current_price\":75.53,\"target_price_6m\":77.0,\"target_price_12m\":79.0,\"recommendation\":\"HOLD\",\"confidence\":0.58,\"thesis_bullets\":[\"Stable healthcare distribution business with modest single-digit revenue growth\",\"Forward PE of 18.2x implies market already prices in moderate earnings recovery\",\"Elevated debt load (~$3.1B) limits financial flexibility amid macro uncertainty\",\"FCF yield of ~4.5% provides reasonable but unexciting return floor\",\"Stock trading 15% below 52-week high suggests limited near-term catalyst\"],\"key_drivers\":[{\"driver\":\"Dental market end-demand recovery trajectory\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Gross margin stability at ~31% amid competitive pressures\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Elevated net debt ($2.9B) constraining capital return flexibility\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Technology solutions platform adoption and recurring revenue mix\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Modest 4% revenue growth limits multiple expansion potential\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Operating margin expansion from cost management initiatives\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Healthcare distribution competitive dynamics and pricing pressure\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Share repurchase program supporting EPS growth above revenue growth\",\"impact\":\"LOW\",\"direction\":\"POS\"}],\"risks\":[\"Dental visit volume decline in economic downturn pressures top-line growth\",\"Continued debt burden limits strategic M&A and shareholder returns\",\"Margin compression from distributor competition and GPO consolidation\",\"Cybersecurity or IT disruption risk given 2023 incident history\",\"Macro tariff uncertainty could raise cost of imported medical supplies\"],\"assumptions\":{\"revenue_cagr_3y\":0.04,\"ebit_margin_target\":0.055,\"wacc\":0.09,\"terminal_multiple\":18.0},\"scenarios\":{\"bear\":{\"target_price\":64.0,\"prob\":0.25,\"notes\":\"Dental market weakness, margin compression, PE contraction to 16x on ~$4.00 EPS.\"},\"base\":{\"target_price\":79.0,\"prob\":0.50,\"notes\":\"Steady 4% growth, modest margin expansion, 18x forward PE on ~$4.30 EPS.\"},\"bull\":{\"target_price\":92.0,\"prob\":0.25,\"notes\":\"Strong dental recovery, tech platform traction drives 20x on ~$4.60 EPS.\"}},\"method_notes\":\"Earnings-power valuation anchored on forward PE (18-20x range for healthcare distribution). Revenue CAGR ~4%, operating leverage drives EPS growth to ~$4.25-4.30 by 12M horizon. EV/EBITDA of 11.4x is inline with distribution peers. Expected 12M return of ~4.6% supports HOLD under rubric. Probability-weighted scenario EV of ~$78.50 is consistent with base target. Not investment advice.\"}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "claude-3.5-ai-equity-research", "risks": [ "Dental visit volume decline in economic downturn pressures top-line growth", "Continued debt burden limits strategic M&A and shareholder returns", "Margin compression from distributor competition and GPO consolidation", "Cybersecurity or IT disruption risk given 2023 incident history", "Macro tariff uncertainty could raise cost of imported medical supplies" ], "ticker": "HSIC", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Steady 4% growth, modest margin expansion, 18x forward PE on ~$4.30 EPS.", "target_price": 79 }, "bear": { "prob": 0.25, "notes": "Dental market weakness, margin compression, PE contraction to 16x on ~$4.00 EPS.", "target_price": 64 }, "bull": { "prob": 0.25, "notes": "Strong dental recovery, tech platform traction drives 20x on ~$4.60 EPS.", "target_price": 92 } }, "confidence": 0.58, "assumptions": { "wacc": 0.09, "revenue_cagr_3y": 0.04, "terminal_multiple": 18, "ebit_margin_target": 0.055 }, "key_drivers": [ { "driver": "Dental market end-demand recovery trajectory", "impact": "HIGH", "direction": "POS" }, { "driver": "Gross margin stability at ~31% amid competitive pressures", "impact": "HIGH", "direction": "POS" }, { "driver": "Elevated net debt ($2.9B) constraining capital return flexibility", "impact": "MED", "direction": "NEG" }, { "driver": "Technology solutions platform adoption and recurring revenue mix", "impact": "MED", "direction": "POS" }, { "driver": "Modest 4% revenue growth limits multiple expansion potential", "impact": "MED", "direction": "NEG" }, { "driver": "Operating margin expansion from cost management initiatives", "impact": "MED", "direction": "POS" }, { "driver": "Healthcare distribution competitive dynamics and pricing pressure", "impact": "MED", "direction": "NEG" }, { "driver": "Share repurchase program supporting EPS growth above revenue growth", "impact": "LOW", "direction": "POS" } ], "method_notes": "Earnings-power valuation anchored on forward PE (18-20x range for healthcare distribution). Revenue CAGR ~4%, operating leverage drives EPS growth to ~$4.25-4.30 by 12M horizon. EV/EBITDA of 11.4x is inline with distribution peers. Expected 12M return of ~4.6% supports HOLD under rubric. Probability-weighted scenario EV of ~$78.50 is consistent with base target. Not investment advice.", "current_price": 75.53, "recommendation": "HOLD", "thesis_bullets": [ "Stable healthcare distribution business with modest single-digit revenue growth", "Forward PE of 18.2x implies market already prices in moderate earnings recovery", "Elevated debt load (~$3.1B) limits financial flexibility amid macro uncertainty", "FCF yield of ~4.5% provides reasonable but unexciting return floor", "Stock trading 15% below 52-week high suggests limited near-term catalyst" ], "target_price_6m": 77, "target_price_12m": 79 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "anthropic", "webSearch": { "enabled": false, "maxToolCalls": 2, "disabledReason": null }, "pauseTurns": 0, "stopReason": "end_turn" }, "sanityIssues": [] }, "latencyMs": 32945, "createdAt": "2026-04-09T05:21:04.289Z", "usage": { "inputTokens": 3565, "outputTokens": 1675, "costUsd": 0.0597 } }, { "id": "cmnr145ra04aap6586221n2et", "runId": "cmnr145r704a5p658lfti2uwk", "modelId": "deepseek.reasoner", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"Equity Research AI\",\n \"as_of\": \"2026-04-08T20:00:02.000Z\",\n \"ticker\": \"HSIC\",\n \"currency\": \"USD\",\n \"current_price\": 75.53,\n \"target_price_6m\": 78.0,\n \"target_price_12m\": 80.0,\n \"recommendation\": \"HOLD\",\n \"confidence\": 0.6,\n \"thesis_bullets\": [\n \"Stable revenue growth in healthcare distribution sector.\",\n \"Modest margin expansion potential from operational efficiency.\",\n \"Strong market position but faces low profitability challenges.\",\n \"Valuation appears fair relative to historical and peer multiples.\",\n \"Mixed growth outlook with sensitivity to economic cycles.\"\n ],\n \"key_drivers\": [\n { \"driver\": \"Healthcare demand stability\", \"impact\": \"HIGH\", \"direction\": \"POS\" },\n { \"driver\": \"Competitive pressure on margins\", \"impact\": \"MED\", \"direction\": \"NEG\" },\n { \"driver\": \"Debt levels manageable with low leverage\", \"impact\": \"LOW\", \"direction\": \"POS\" },\n { \"driver\": \"Economic cycles affecting healthcare spending\", \"impact\": \"MED\", \"direction\": \"NEG\" },\n { \"driver\": \"Digital adoption in distribution channels\", \"impact\": \"MED\", \"direction\": \"POS\" },\n { \"driver\": \"Regulatory changes in healthcare industry\", \"impact\": \"HIGH\", \"direction\": \"NEG\" },\n { \"driver\": \"EPS growth momentum from cost controls\", \"impact\": \"MED\", \"direction\": \"POS\" },\n { \"driver\": \"Valuation multiples compression risk\", \"impact\": \"MED\", \"direction\": \"NEG\" }\n ],\n \"risks\": [\n \"Economic downturn reducing discretionary healthcare spending\",\n \"Increased competition from online and direct distributors\",\n \"Regulatory compliance costs and changes\",\n \"Supply chain disruptions impacting inventory\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.045,\n \"ebit_margin_target\": 0.055,\n \"wacc\": 0.08,\n \"terminal_multiple\": 10.0\n },\n \"scenarios\": {\n \"bear\": { \"target_price\": 70.0, \"prob\": 0.2, \"notes\": \"Weak economic conditions pressure margins and growth.\" },\n \"base\": { \"target_price\": 80.0, \"prob\": 0.6, \"notes\": \"Steady growth with stable valuation multiples.\" },\n \"bull\": { \"target_price\": 90.0, \"prob\": 0.2, \"notes\": \"Strong margin improvement and market share gains.\" }\n },\n \"method_notes\": \"Valuation based on DCF with assumptions as labeled. HOLD due to limited upside (~6%) and balanced risks. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "Equity Research AI", "risks": [ "Economic downturn reducing discretionary healthcare spending", "Increased competition from online and direct distributors", "Regulatory compliance costs and changes", "Supply chain disruptions impacting inventory" ], "ticker": "HSIC", "currency": "USD", "scenarios": { "base": { "prob": 0.6, "notes": "Steady growth with stable valuation multiples.", "target_price": 80 }, "bear": { "prob": 0.2, "notes": "Weak economic conditions pressure margins and growth.", "target_price": 70 }, "bull": { "prob": 0.2, "notes": "Strong margin improvement and market share gains.", "target_price": 90 } }, "confidence": 0.6, "assumptions": { "wacc": 0.08, "revenue_cagr_3y": 0.045, "terminal_multiple": 10, "ebit_margin_target": 0.055 }, "key_drivers": [ { "driver": "Healthcare demand stability", "impact": "HIGH", "direction": "POS" }, { "driver": "Competitive pressure on margins", "impact": "MED", "direction": "NEG" }, { "driver": "Debt levels manageable with low leverage", "impact": "LOW", "direction": "POS" }, { "driver": "Economic cycles affecting healthcare spending", "impact": "MED", "direction": "NEG" }, { "driver": "Digital adoption in distribution channels", "impact": "MED", "direction": "POS" }, { "driver": "Regulatory changes in healthcare industry", "impact": "HIGH", "direction": "NEG" }, { "driver": "EPS growth momentum from cost controls", "impact": "MED", "direction": "POS" }, { "driver": "Valuation multiples compression risk", "impact": "MED", "direction": "NEG" } ], "method_notes": "Valuation based on DCF with assumptions as labeled. HOLD due to limited upside (~6%) and balanced risks. Not investment advice.", "current_price": 75.53, "recommendation": "HOLD", "thesis_bullets": [ "Stable revenue growth in healthcare distribution sector.", "Modest margin expansion potential from operational efficiency.", "Strong market position but faces low profitability challenges.", "Valuation appears fair relative to historical and peer multiples.", "Mixed growth outlook with sensitivity to economic cycles." ], "target_price_6m": 78, "target_price_12m": 80 }, "errorsJson": { "attempts": [], "providerMeta": { "endpoint": "https://api.deepseek.com/v1/chat/completions", "provider": "deepseek", "webSearch": { "enabled": false, "supported": false }, "responseFormat": "json_object" }, "sanityIssues": [] }, "latencyMs": 377, "createdAt": "2026-04-09T05:21:04.289Z", "usage": { "inputTokens": 2082, "outputTokens": 3797, "costUsd": 0.002178 } }, { "id": "cmnr145ra04a8p658t61um8d5", "runId": "cmnr145r704a5p658lfti2uwk", "modelId": "gemini.3-pro", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"EquityResearch_v1.0\",\n \"as_of\": \"2026-04-08T20:00:02.000Z\",\n \"ticker\": \"HSIC\",\n \"currency\": \"USD\",\n \"current_price\": 75.53,\n \"target_price_6m\": 78.00,\n \"target_price_12m\": 82.00,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.65,\n \"thesis_bullets\": [\n \"Leading market share in dental and medical distribution provides durable competitive advantages.\",\n \"Cybersecurity incident recovery is largely complete, stabilizing near-term revenue streams.\",\n \"High interest rates continue to pressure big-ticket dental equipment purchases.\",\n \"DSO consolidation presents volume opportunities but threatens long-term gross margins.\",\n \"Valuation at 11.4x EV/EBITDA is fair, offering moderate upside potential.\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Dental equipment sales\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"DSO market consolidation\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Interest rate environment\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Software and value-added services growth\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Medical supply volumes\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Operating margin expansion initiatives\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n }\n ],\n \"risks\": [\n \"Prolonged high interest rates delaying capital equipment purchases by practitioners.\",\n \"Accelerated DSO consolidation reducing pricing power and gross margins.\",\n \"Lingering market share losses from the late-2023 cybersecurity breach.\",\n \"Macroeconomic slowdown reducing elective dental procedures.\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.045,\n \"ebit_margin_target\": 0.065,\n \"wacc\": 0.082,\n \"terminal_multiple\": 11.5\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 62.00,\n \"prob\": 0.2,\n \"notes\": \"Persistent inflation and high rates delay equipment purchases, squeezing margins.\"\n },\n \"base\": {\n \"target_price\": 82.00,\n \"prob\": 0.6,\n \"notes\": \"Steady recovery in dental equipment sales and stable operating margins.\"\n },\n \"bull\": {\n \"target_price\": 95.00,\n \"prob\": 0.2,\n \"notes\": \"Strong macro recovery and lower rates spur equipment upgrades and software adoption.\"\n }\n },\n \"method_notes\": \"Blended valuation using 11.5x EV/EBITDA and 18x forward P/E. Upside of ~8.5% warrants a BUY rating. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "EquityResearch_v1.0", "risks": [ "Prolonged high interest rates delaying capital equipment purchases by practitioners.", "Accelerated DSO consolidation reducing pricing power and gross margins.", "Lingering market share losses from the late-2023 cybersecurity breach.", "Macroeconomic slowdown reducing elective dental procedures." ], "ticker": "HSIC", "currency": "USD", "scenarios": { "base": { "prob": 0.6, "notes": "Steady recovery in dental equipment sales and stable operating margins.", "target_price": 82 }, "bear": { "prob": 0.2, "notes": "Persistent inflation and high rates delay equipment purchases, squeezing margins.", "target_price": 62 }, "bull": { "prob": 0.2, "notes": "Strong macro recovery and lower rates spur equipment upgrades and software adoption.", "target_price": 95 } }, "confidence": 0.65, "assumptions": { "wacc": 0.082, "revenue_cagr_3y": 0.045, "terminal_multiple": 11.5, "ebit_margin_target": 0.065 }, "key_drivers": [ { "driver": "Dental equipment sales", "impact": "HIGH", "direction": "POS" }, { "driver": "DSO market consolidation", "impact": "HIGH", "direction": "NEG" }, { "driver": "Interest rate environment", "impact": "MED", "direction": "NEG" }, { "driver": "Software and value-added services growth", "impact": "MED", "direction": "POS" }, { "driver": "Medical supply volumes", "impact": "MED", "direction": "POS" }, { "driver": "Operating margin expansion initiatives", "impact": "MED", "direction": "POS" } ], "method_notes": "Blended valuation using 11.5x EV/EBITDA and 18x forward P/E. Upside of ~8.5% warrants a BUY rating. Not investment advice.", "current_price": 75.53, "recommendation": "BUY", "thesis_bullets": [ "Leading market share in dental and medical distribution provides durable competitive advantages.", "Cybersecurity incident recovery is largely complete, stabilizing near-term revenue streams.", "High interest rates continue to pressure big-ticket dental equipment purchases.", "DSO consolidation presents volume opportunities but threatens long-term gross margins.", "Valuation at 11.4x EV/EBITDA is fair, offering moderate upside potential." ], "target_price_6m": 78, "target_price_12m": 82 }, "errorsJson": { "attempts": [], "providerMeta": { "model": "gemini-3-pro-preview", "provider": "gemini", "webSearch": { "used": false, "allowed": false, "enabled": false, "requested": false, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 23695, "createdAt": "2026-04-09T05:21:04.289Z", "usage": { "inputTokens": 2427, "outputTokens": 801, "costUsd": 0.014466 } }, { "id": "cmnr145ra04a6p6583ggmekwk", "runId": "cmnr145r704a5p658lfti2uwk", "modelId": "openai.gpt-5.4", "status": "SUCCESS", "rawOutput": "{\"model\":\"OpenAI o3\",\"as_of\":\"2026-04-08T20:00:02.000Z\",\"ticker\":\"HSIC\",\"currency\":\"USD\",\"current_price\":75.53,\"target_price_6m\":77,\"target_price_12m\":78.5,\"recommendation\":\"HOLD\",\"confidence\":0.62,\"thesis_bullets\":[\"Defensive dental and medical distribution supports steady low-single-digit sales growth.\",\"Margin recovery offers upside, but current profitability remains thin.\",\"Valuation looks reasonable, not clearly cheap, at mid-teens forward earnings.\",\"Strong cash generation helps deleveraging despite sizable absolute debt.\",\"Mixed growth and leverage signals justify a neutral stance.\"],\"key_drivers\":[{\"driver\":\"Dental consumables resilience\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Equipment demand normalization\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Margin recovery execution\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Practice software/services mix\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Procedure volume trends\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Net debt burden\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Thin operating margin\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Working capital intensity\",\"impact\":\"LOW\",\"direction\":\"NEG\"}],\"risks\":[\"Prolonged dental equipment weakness\",\"Margin recovery misses expectations\",\"Supplier pricing or freight inflation\",\"Higher rates pressure cash flow\"],\"assumptions\":{\"revenue_cagr_3y\":0.045,\"ebit_margin_target\":0.058,\"wacc\":0.09,\"terminal_multiple\":11.8},\"scenarios\":{\"bear\":{\"target_price\":66,\"prob\":0.25,\"notes\":\"Equipment softness and margin pressure keep earnings near current run-rate.\"},\"base\":{\"target_price\":78.5,\"prob\":0.5,\"notes\":\"Low-single-digit growth and modest margin recovery support near-fair value.\"},\"bull\":{\"target_price\":88,\"prob\":0.25,\"notes\":\"Procedure rebound and mix improvement lift margins and valuation.\"}},\"method_notes\":\"Uses snapshot fundamentals with a blended forward P/E and EV/EBITDA sanity check; targets reflect low-single-digit growth, modest margin recovery, and leverage drag. Snapshot quote fields kept authoritative; no sell-side targets used. not investment advice\"}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "OpenAI o3", "risks": [ "Prolonged dental equipment weakness", "Margin recovery misses expectations", "Supplier pricing or freight inflation", "Higher rates pressure cash flow" ], "ticker": "HSIC", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Low-single-digit growth and modest margin recovery support near-fair value.", "target_price": 78.5 }, "bear": { "prob": 0.25, "notes": "Equipment softness and margin pressure keep earnings near current run-rate.", "target_price": 66 }, "bull": { "prob": 0.25, "notes": "Procedure rebound and mix improvement lift margins and valuation.", "target_price": 88 } }, "confidence": 0.62, "assumptions": { "wacc": 0.09, "revenue_cagr_3y": 0.045, "terminal_multiple": 11.8, "ebit_margin_target": 0.058 }, "key_drivers": [ { "driver": "Dental consumables resilience", "impact": "HIGH", "direction": "POS" }, { "driver": "Equipment demand normalization", "impact": "MED", "direction": "POS" }, { "driver": "Margin recovery execution", "impact": "HIGH", "direction": "POS" }, { "driver": "Practice software/services mix", "impact": "MED", "direction": "POS" }, { "driver": "Procedure volume trends", "impact": "MED", "direction": "POS" }, { "driver": "Net debt burden", "impact": "MED", "direction": "NEG" }, { "driver": "Thin operating margin", "impact": "HIGH", "direction": "NEG" }, { "driver": "Working capital intensity", "impact": "LOW", "direction": "NEG" } ], "method_notes": "Uses snapshot fundamentals with a blended forward P/E and EV/EBITDA sanity check; targets reflect low-single-digit growth, modest margin recovery, and leverage drag. Snapshot quote fields kept authoritative; no sell-side targets used. not investment advice", "current_price": 75.53, "recommendation": "HOLD", "thesis_bullets": [ "Defensive dental and medical distribution supports steady low-single-digit sales growth.", "Margin recovery offers upside, but current profitability remains thin.", "Valuation looks reasonable, not clearly cheap, at mid-teens forward earnings.", "Strong cash generation helps deleveraging despite sizable absolute debt.", "Mixed growth and leverage signals justify a neutral stance." ], "target_price_6m": 77, "target_price_12m": 78.5 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "openai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "resp_0e019a9d481f0a1c0069d759e225d481939de11eca96adb896", "reasoningEffort": "medium", "structuredOutputs": { "used": true, "requested": true, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 37317, "createdAt": "2026-04-09T05:21:04.289Z", "usage": { "inputTokens": 2351, "outputTokens": 1924, "costUsd": 0.03105 } }, { "id": "cmnr145ra04a9p658nl7ln9xs", "runId": "cmnr145r704a5p658lfti2uwk", "modelId": "xai.grok-4.20-reasoning", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"AI Model Recommendation\",\n \"as_of\": \"2026-04-08T20:00:02.000Z\",\n \"ticker\": \"HSIC\",\n \"currency\": \"USD\",\n \"current_price\": 75.53,\n \"target_price_6m\": 77,\n \"target_price_12m\": 80,\n \"recommendation\": \"HOLD\",\n \"confidence\": 0.6,\n \"thesis_bullets\": [\n \"Global leader in dental and medical product distribution\",\n \"Modest 4-6% annual revenue growth expected\",\n \"Potential for operating margin expansion\",\n \"Significant debt load adds financial risk\",\n \"Fair valuation with limited near-term upside\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Healthcare practitioner demand\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Supply chain optimization\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"International market expansion\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Debt servicing costs\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Competitive pressures\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Inflation on product costs\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Acquisition synergies\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Regulatory changes\",\n \"impact\": \"LOW\",\n \"direction\": \"NEG\"\n }\n ],\n \"risks\": [\n \"Economic slowdown reducing practitioner spend\",\n \"Competition from digital and online distributors\",\n \"Rising interest rates on high debt\",\n \"Supply chain and inflation pressures\",\n \"FX volatility in global operations\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.05,\n \"ebit_margin_target\": 0.055,\n \"wacc\": 0.09,\n \"terminal_multiple\": 14\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 65,\n \"prob\": 0.3,\n \"notes\": \"Weak demand and margin compression from competition.\"\n },\n \"base\": {\n \"target_price\": 80,\n \"prob\": 0.5,\n \"notes\": \"Stable execution with modest growth and margins.\"\n },\n \"bull\": {\n \"target_price\": 95,\n \"prob\": 0.2,\n \"notes\": \"Accelerated growth and efficiency gains.\"\n }\n },\n \"method_notes\": \"DCF using 5% revenue CAGR, 5.5% EBIT margin, 9% WACC and 14x terminal EV/EBITDA. Mixed growth and fair valuation support HOLD. not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:02.000Z", "model": "AI Model Recommendation", "risks": [ "Economic slowdown reducing practitioner spend", "Competition from digital and online distributors", "Rising interest rates on high debt", "Supply chain and inflation pressures", "FX volatility in global operations" ], "ticker": "HSIC", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Stable execution with modest growth and margins.", "target_price": 80 }, "bear": { "prob": 0.3, "notes": "Weak demand and margin compression from competition.", "target_price": 65 }, "bull": { "prob": 0.2, "notes": "Accelerated growth and efficiency gains.", "target_price": 95 } }, "confidence": 0.6, "assumptions": { "wacc": 0.09, "revenue_cagr_3y": 0.05, "terminal_multiple": 14, "ebit_margin_target": 0.055 }, "key_drivers": [ { "driver": "Healthcare practitioner demand", "impact": "HIGH", "direction": "POS" }, { "driver": "Supply chain optimization", "impact": "MED", "direction": "POS" }, { "driver": "International market expansion", "impact": "MED", "direction": "POS" }, { "driver": "Debt servicing costs", "impact": "HIGH", "direction": "NEG" }, { "driver": "Competitive pressures", "impact": "MED", "direction": "NEG" }, { "driver": "Inflation on product costs", "impact": "MED", "direction": "NEG" }, { "driver": "Acquisition synergies", "impact": "MED", "direction": "POS" }, { "driver": "Regulatory changes", "impact": "LOW", "direction": "NEG" } ], "method_notes": "DCF using 5% revenue CAGR, 5.5% EBIT margin, 9% WACC and 14x terminal EV/EBITDA. Mixed growth and fair valuation support HOLD. not investment advice.", "current_price": 75.53, "recommendation": "HOLD", "thesis_bullets": [ "Global leader in dental and medical product distribution", "Modest 4-6% annual revenue growth expected", "Potential for operating margin expansion", "Significant debt load adds financial risk", "Fair valuation with limited near-term upside" ], "target_price_6m": 77, "target_price_12m": 80 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "xai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "a5cf2884-f3be-9a5a-b8f1-9d52052ab7de", "usedFallbackChatCompletions": false }, "sanityIssues": [] }, "latencyMs": 17647, "createdAt": "2026-04-09T05:21:04.289Z", "usage": { "inputTokens": 2690, "outputTokens": 4402, "costUsd": 0.0741 } } ] } }